Oramed Pharmaceuticals Inc. (NasdaqCM:ORMP) announces a share repurchase program. Under the program, the company will repurchase up to $20 million worth of its shares. The program will expired in 12 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | -4.10% |
|
+11.74% | +11.26% |
26/06 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
26/06 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.26% | 10Cr | |
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.6TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.06TCr |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares.